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1. Introduction 
The importance of structural biology has been highlighted in the past few years not only as 
part of drug discovery programs in the pharmaceutical industry but also by structural 
genomics programs. Mutations of human proteins have been long recognized as the source 
of severe diseases and a structural knowledge of the consequences of a mutation might open 
up new approaches of drugs and cure. Although the function of a protein can be studied by 
several biochemical and/or biophysical techniques, a detailed molecular understanding of 
the protein of interest can only be obtained by combining functional data with the 
knowledge of the three-dimensional structure. In principle three techniques exist to 
determine a protein structure, namely X-ray crystallography, nuclear magnetic resonance 
spectroscopy (NMR) and electron microscopy (EM). According to the protein data bank 
(pdb; http://www.rcsb.org) that provides a general and open-access platform for structures 
of biomolecules, X-ray crystallography contributes more than 90% of all structures in the 
pdb, a clear emphasis of the importance of this technique.  
To perform X-ray crystallography it is essential to have large amounts of pure and 
homogenous protein to perform an even today still “trail and error”-based screening matrix 
to obtain well diffracting protein crystals. Therefore, successful protein crystallization 
requires three major and crucial steps, all of them associate with specific problems and 
challenges that need to be overcome and solved. These steps are (I) protein expression, (II) 
protein purification and (III) the empirical search for crystallization conditions. As 
summarized in Figure 1, every single step needs to be optimized along the long and stoney 
road to obtain protein crystals suitable for structure determination of your “most-beloved” 
protein via X-ray crystallography. This chapter will focus on these three steps and suggests 
strategies how to perform and optimize each of these three steps on the road of protein 
structure determination. 
2. Protein expression (I) 
To crystallize a protein, the first requirement is the expression of your protein in high 
amounts and most importantly on a regular basis. This implies that it is possible to obtain a 
freshly purified protein at least weekly. In general, it is possible to express a protein either 
homologously or heterologously (see Figure 1 – (I) expression). Especially for large proteins,  
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Fig. 1. Schema highlighting the three steps towards a protein crystal. (I) Expression (II) 
Purification (III) Protein crystallization. 
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proteins containing a co-factor or a ligand, the natural habitat is likely the best choice to 
express the protein. However, often the natural host, for example humans, produce only 
low amounts of protein and suitable overexpression protocolls are not available. To 
circumvent this problem, several expression strains, cell lines as well as a large number of 
expression vectors have been developed to allow expression of any protein in a different 
host (heterologous expression). In general, the used organisms for protein expression can be 
divided into two different groups: prokaryotic and eukaryotic expression hosts. The natural 
organism of the protein of interest mainly dictates the choice, which expression system to 
use. If working with a bacterial protein, it is very likely that also a prokaryotic host is able to 
express the protein in high amounts. The same holds true for proteins originating from a 
eukaryotic host, which is likely best overexpressed in a eukaryotic host. These proteins often 
require posttranslational modification such as glycosylation or disulfide bond formation, 
which are possible in eukaryotic expression hosts. The most common used heterologous 
expression host is the gram negative bacteria Escherichia coli since it is commercially 
available and a large number of expression cassettes have been developed. Thus, it is the 
most widely used expression system with expression rates of several mg/L of culture. The 
best characterised and understood expression hosts are described in more detail below and 
the commecially available systems are listed in table 1. 
2.1 Expression hosts – Prokaryotic 
2.1.1 Gram negative - E. coli 
As mentioned above, E. coli is the most common used expression system (Figure 1 – (I) 
expression, left side). This is further highlighted by the fact that 80% of all protein structures 
deposited in the protein data bank were overexpressed in E. coli (Sorensen and Mortensen 
2005). There are several advantages promoting E. coli as expression host: (A) Cultivation of E. 
coli is simple and a doubling time of 30 minutes is rather quick allowing the fast generation of 
biomass, (B) genetics are well understood and any genetical manipulation is well established, 
(C) expression levels of up to 60 % of the total protein mass within the cell make the next step, 
protein purification rather straight forward and finally (D) the cultivation does require only 
standard equipment normally present in every biochemical laboratory and therefore 
expression using E.coli is relatively cheap. In the last decades, many different plasmid based 
expression systems have been developed such as the pET vector systems, which contain 
several different expression plasmids with a choice for the affinity tag on either termini of the 
protein as well as the possiblity to use a dual cassette when expressing two or more proteins at 
once. The selection pressure derived from different antibiotics, and the resistance genes 
encoded on these plasmids further simplify laboratory practice. Only cells harbouring the right 
plasmids are able to grow and therefore expenditure on sterility is low.  
The typical E. coli expression system is plasmid-based, which can be transferred to different 
E. coli strains ((Sorensen and Mortensen 2005), Novagen pET vector table). An E. coli 
expression vector consists mainly of five important parts: the replicon, a resistance marker, a 
promotor and a so-called multiple cloning site (MCS) (Baneyx 1999; Jonasson, Liljeqvist et 
al. 2002). The replicon is the crucial part of a plasmid to maintain it inside a cell. It is 
recognized and duplicated by the replication machinery (Baneyx 1999). The selection marker 
allows the identification of cells carrying a plasmid as it encodes for a resistance, e.g. against 
antibiotics (see above)(Sorensen and Mortensen 2005). The promotor sequence is the 
recognition site for the RNA polymerase, however it is inactive under initial cultivation 
conditions. The addition of an inducer (sometimes also a temperature change) switches the 
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promotor from ‘off’ to ‘on’ whereby the expression is initiated (Jana and Deb 2005). 
Common inducers are isopropyl-β-D-thiogalactopyranosid (IPTG) in the pET system or 
arabinose for pBAD vectors (Invitrogen™). The multiple cloning site (MCS) is a short DNA 
segment combining many (up to 20) restriction sites. This feature simplified the insertion of 
genes into the plasmid enormously and made cloning procedures very convenient. 
However, new cloning strategies, which are independent of restriction enzymes and ligases, 
are emerging and will replace the standard approaches some day (see for example Li and 
Elledge 2007). 
2.1.2 Gram positive - L. lactis 
Within the prokaryotic expression system also some gram (+) bacteria are used for protein 
overexpression (Figure 1 – (I) expression left side). Here, lactic acid bacteria play a privotal 
role. They are used in food industry and are known since 1873 when Joseph Lister isolated the 
first strain (Teuber 1995; Mierau and Kleerebezem 2005). For the overexpression of 
recombinant proteins, there are many lactic acid bacteria around, lactococci, lactobacilli, 
streptococci and leuconostocs. (Gasson 1983; van de Guchte, Kok et al. 1992; de Vos and Vaughan 
1994). The best characterized and most widely used host is Lactococcus lactis, which is famous 
for its usage within food fermentation and like for E. coli the genome, metabolisms and 
molecular modifications are well known and established (Bolotin, Wincker et al. 2001; Guillot, 
Gitton et al. 2003). Thus, it has been called the ‘bug of the next millennium’(Konings, Kok et al. 
2000). All established gram (+) bacteria expression hosts are able to overexpress proteins 
homologously or heterologously. Since only one, namely the cyctoplasmic membrane is 
present (Kunji, Slotboom et al. 2003), this host is in comparison to the two-membrane system 
of gram (-) bacteria, a good choice to express eukaryotic as well as prokaryotic membrane 
proteins or proteins with membrane anchors (Kunji, Slotboom et al. 2003). The promoter used 
for expression in L. lactis is induced by the external addition of nisin. Nisin is an antimicrobial 
active peptide, which interacts with lipid II in the cytoplasmic membrane of gram (+) bacteria 
and causes cell lysis. Interestingly, nisin is produced by L. lactis itself. The expression strain is 
deleted of the nisin producing genes and therefore external nisin can be used as inductor. 
Nisin binds to NisK, which as part of a two-component system, phosphorylates NisR, which in 
turn binds to the promotor PnisA thereby allowing synthesis of the protein located downstream 
on the plasmid. Since nisin is also active against L. lactis itself, the concentration range of nisin 
used in such expression studies is relatively narrow to circumvent killing of the L. lactis 
expression strain. This is clearly a draw back of this expression system since expression can 
basically only turned on with a certain nisin concentration. Between the inducer concentration 
and the expressed protein a linear behaviour is observed. Unfortunately the nisin 
concentration range between the minimal and maximum nisin concentration is very small, 
nisin concentration higher than 25 ng per liter of cells, cause cell death. 
However, L. lactis has been proven to be a very efficient expression system. Kuipers et al. 
created many expression hosts and plasmids to produce any protein of interest by cloning it 
downstream of the PnisA promotor. With this nisin inducible (NICE) expression system, it is 
now possible to induce the protein production with minimal concentration (0.1 – 5 ng) of 
nisin (de Ruyter, Kuipers et al. 1996; Kuipers, de Ruyter et al. 1998). The amount of 
produced recombinant protein can reach up to 50 % of the total intracellular proteins 
(Kuipers, Beerthuyzen et al. 1995; de Ruyter, Kuipers et al. 1996). Following a few examples 
for expressed proteins in L. lactis whose structures have been solved: an ECF-type ABC 
transporter (PDB:3RLB)(Erkens, Berntsson et al. 2011), a peptide binding protein OppA 
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(PDB:3RYA)(Berntsson, Doeven et al. 2009) and the multidrug binding transcriptional 
regulator LmrR (PDB:3F8B)(Madoori, Agustiandari et al. 2009). 
2.2 Eukaryotic expression hosts 
The great benefit of choosing a eukaryotic host for overexpression of a protein of interest 
are the availability of a posttranslational modification system as well as the frequently 
enhanced protein folding (Midgett and Madden 2007). Eukaryotic proteins tend to 
misfold or lack biological activity when expressed in prokaryotic expression systems such 
as E. coli (Cregg, Cereghino et al. 2000; Midgett and Madden 2007). To overexpress these 
proteins, different yeast strains, insect cells or even mammalian cell lines have been 
developed as expression hosts (Figure 1 - (I) expression, right side). Eukaryotic expression 
systems are often more expensive, provide low expression levels and are sometimes hard 
to handle, when compared to bacterial systems. However, the genetic and cellular 
contexts are more similar to the original protein-expressing organism (Midgett and 
Madden 2007). In the following sections, some of the commonly employed eukaryotic 
expression systems will be described. 
2.2.1 Yeast expression systems - Saccharomyces cerevisiae and Pichia pastoris 
The most widely used yeast strains to express protein are Saccharomyces cerevisiae and Pichia 
pastoris, which offer the major advantage of a posttranslational modification system for 
glycosylation, proteolytic processing as well as disulfide bond formation, which for some 
proteins are essential for the function and/or correct folding (Cregg, Cereghino et al. 2000; 
Midgett and Madden 2007). The handling of yeast expression systems is similar to 
prokaryotic systems with respect to the genetic background and cultivation. Similar to the 
bacterial vector systems, expression in yeast starts with a plasmid-based cloning part which 
can be performed in E. coli (Cregg 2007). Afterwards the expression cassette gets integrated 
into the genome by simple homologous recombination in the yeast. One major advantage in 
P. pastoris is the insertion of multiple copies of the protein DNA-sequence into genomic 
DNA, which increases expression yield. 
The biggest advantage of yeast as expression system is that well established protocols for 
fermentation are available. Optimal fermentation of P. pastoris can end up with more than 
130 gram of cells per liter of culture. Even if expression levels in the cell are not that high the 
mass of cells easily compensates for this disadvantage (Wegner 1990; Cregg, Cereghino et al. 
2000; Hunt 2005; Cregg 2007; Midgett and Madden 2007). Examples of crystal structures 
from proteins expressed in P. pastoris are a human monoamine oxidase B (PDB:3PO7) 
(Binda, Aldeco et al. 2010) and a protein involved in cell adhesion NCAM2 IG3-4 
(PDB:2XY1)(Kulahin, Kristensen et al. 2011). 
2.2.2 Insect cells 
The expression system in insect cells is beside yeast a well-characterised alternative to 
express eukaryotic proteins (Midgett and Madden 2007). As insect cells are higher 
eukaryotic systems their posttranslational modification machinery can carry out more 
complex alterations than yeast strains. They also have a machinery for the folding of 
mammalian proteins. The most commonly used vector system for recombinant protein 
expression in insect cells is baculovirus, which can also be used for gene transfer and 
expression in mammalian cells (Smith, Summers et al. 1983; D., L.K. et al. 1992; Altmann, 
Staudacher et al. 1999). A few examples of proteins expressed in insect cells that resulted in 
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crystal structures are the transferase Ack1 (PDB:3EQP)(Kopecky, Hao et al. 2008), a human 
hydrolase (PDB: 2PMS)(Senkovich, Cook et al. 2007) and myosin VI (PDB:2BKI)(Menetrey, 
Bahloul et al. 2005). 
2.2.3 Mammalian cell lines 
The expression of proteins in mammalian cell lines is the most expensive and complex 
alternative. Especially for human membrane proteins this expression system has been 
proven to express the most active protein (Tate, Haase et al. 2003; Lundstrom 2006; 
Lundstrom, Wagner et al. 2006; Eifler, Duckely et al. 2007). The resulting protein amount, 
however, obtained from mammalian cell lines is mostly only sufficient for functional 
studies. Using mammalian cells lines is the most challenging variant of protein 
overexpression and therefore only choosen if any of the other expression system described 
failed. Some examples of protein structures expressed in mammalian cell lines are the 
hydrolase PCSK9 (PDB:2QTW)(Hampton, Knuth et al. 2007) and the acetylcholine receptor 
AChBP (PDB:2BYQ)(Hansen, Sulzenbacher et al. 2006). 
Table 1 sums up advantages and disadvantages of the above mentioned overexpression 
systems used for protein crystallography.  
 
 
Table 1. Overview of expression systems. Summarized are the advantages and 
disadvantages. 
www.intechopen.com
 Rational and Irrational Approaches to Convince a Protein to Crystallize 
 
503 
3. Purification 
After having expressed your protein of interest, the race for crystals is by no means finished. 
The next step on the long road to structure determination is to isolate the protein or - 
phrasing it differently - to remove all other proteins present in the cell (Figure 1 – (II) 
purification). An elegant method to do so is the genetic attachment of an affinity tag on 
either site of the protein or in some cases on both sides (Waugh 2005). This affinity tag has 
the possibility to bind high affine to a immobilized ligand on a matrix, while all other 
proteins have a much more reduced binding affinity and therefore flow through the matrix 
(Figure 1 – (II) purification 1st step). This allows a one-step purification, which in almost all 
cases is relatively harmless for the protein and likely does not interfere with folding and/or 
overall structure of the protein. There are a lot of affinity tags available as well as matrix 
materials (Terpe 2003). The well known and most often used affinity tag is the poly-histidine 
tag (Porath, Carlsson et al. 1975; Gaberc-Porekar and Menart 2001), which can vary in length 
as well as in position but the overall purification strategy is the same. From all the structures 
solved nowadays, almost 60 % of the proteins are purified via a histidine tag; mainly due to 
the great purification efficiency, which can be as large as 90% after a single purification step 
(Gaberc-Porekar and Menart 2001; Arnau, Lauritzen et al. 2006). Therefore, most 
commercially available expression systems and methods contain a his-tag encoded on the 
plasmid. Besides the his-tag, there are other tags avaible and used for protein purification, of 
which the Strep-, CBP-, GST-, MBP-tag are described below. 
3.1 Choice of the right tag 
3.1.1 Polyhistidine-tag (his-tag) 
As mentioned above the polyhistidine-tag is the most common affinity tag and the required 
affinity resins and chemicals are relatively inexpensive. The purification step is a so-called 
immobilized metal ion affinity chromatography (IMAC) (Porath, Carlsson et al. 1975). Here, 
a matrix is able to bind bivalent metal ions. For example nitrilotriactetic acid (NTA), which 
is a chelator and binds metal ions like Ni2+, Zn2+, Co2+ or Cu2+ (Hochuli, Dobeli et al. 1987).  
These metal ions have a high affinity to the imidazole group of the amino acid histidine. A 
stretch of histindines in a row with for example an E. coli protein is very unusual. Thus, the 
genetical introduction of several, in most cases 6- 10 histidines in a row selects for specific 
binding of this protein. As eluant very elegantly imidazole can be used, which competes 
with the histidine tag and elutes the protein of interest. When used in low concentrations, 
imidazole can also be used to remove unspecifically bound proteins, which bind with low 
affinity to the matrix (Hefti, Van Vugt-Van der Toorn et al. 2001). Normally, a protein with a 
6-10 histidine tag should be bound to the matrix relative strongly and 100-250 mM 
imidazole in the buffer is required to elute the protein from the resin. In contrast, proteins 
with a low affinity to the matrix can already be eluted with 10-50 mM imidazole (the 
“impurities” of E. coli). Therefore, a linear imidazol gradient, for example, separates the 
protein of interest and impurities (Hochuli, Dobeli et al. 1987; Gaberc-Porekar and Menart 
2001). Although the polyhistidine-tag is the most common and mostly an efficient variant, 
there are a few applications where the his-tag can cause problems. Metalloproteins can 
interact either directly with the his-tag or with the ions immobilized on the matrix. In 
comparison to some other affinity-tags, the specificity of the his-tag is not that high and in 
some cases this results in the co-purification of other proteins (Waugh 2005).  
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3.1.2 Strep-tag 
In comparison to the his-tag, which binds to immobilized metal ions, the strep-tag II constists 
of a small octapeptide (WSHPQFEK), which binds to the protein streptavidin (Schmidt, 
Koepke et al. 1996). The commercial available matrix is a streptavidin variant and is called 
Strep-Tactin. This variant is able to bind the Strep-tag II octapeptide under mild buffer 
conditions and can be gently eluted with biotin derivates such as desthiobiotin (Schmidt, 
Koepke et al. 1996; Voss and Skerra 1997). Especially for metal-ion containing enzymes it is a 
promising alternative to the his-tag (Groß, Pisa et al. 2002). However, as chemicals are more 
expensive and the matrix has a lower binding capacity, compared to NTA resins, it is often not 
the first option choosen. Moreover, it cannot be used under denaturating conditions since 
Strep-Tactin denatures and will not bind the tag anymore (Terpe 2003; Waugh 2005). Examples 
of proteins crystallized after a Strep-tag purification are OpuBC (PDB:3R6U)(Pittelkow, 
Tschapek et al. 2011) and AfProX (PDB:3MAM)(Tschapek, Pittelkow et al. 2011) as well as the 
sodium dependent glycine betain transporter BetP from Corynebacterium glutamicum 
(PDB:2WIT)(Ressl, Terwisscha van Scheltinga et al. 2009). 
3.1.3 CBP-tag 
Another peptide tag, is the calmodulin binding peptide, first described in 1992 (Stofko-
Hahn, Carr et al. 1992). This peptide is prolonged compared to the Strep-tag II, consisting of 
26 amino acids and binds with nanomolar affinity to calmodulin in the presence of Ca2+ 
(Blumenthal, Takio et al. 1985). It is derived from the C-terminus of the skeletal-muscle 
myosin light-chain kinase, which makes the system an excellent choice for proteins 
expressed using a prokaryotic expression system, since in prokaryotic systems nearly no 
protein interacts with calmodulin. This allows extensive washing to remove impurities and 
elution with EGTA, which complexes specifically Ca2+, and a protein recovery around 90 % 
can be achieved (Terpe 2003). A drawback of this tag however is that the CBP tag can only 
be fused to the C-terminus of the protein since it has been shown that CBP on the N-
terminus negatively influences the translation and thereby the expression rate (Zheng, 
Simcox et al. 1997).  
3.1.4 GST-tag 
With respect to the length of the tags, the his-tag contains only a few amino acids, the Strep-
tag II and the CBP-tag already contain 8 – 26 amino acids, but it is possible to fuse whole 
proteins with 26 – 40 kDa to a recombinant protein. Here, the high affinity binding of the 
protein to their substrate is used to purify the protein of interest (Smith and Johnson 1988). 
In the case of the glutathione S-transferase (GST, 26 kDa) the protein specifically binds to 
immobilized glutathione. To elute the fusion protein from the resin, non-denaturating buffer 
conditions employing reduced glutathione are used (Terpe 2003). The tag can help to protect 
the recombinant protein from degradation by cellular proteases. It is recommended to 
cleave off the GST-tag after purification with a specific protease like thrombin or TEV 
(Tobacco Etch Virus) protease (Terpe 2003).  
3.1.5 MBP-tag 
Another affnitiy tag, which can be fused to the protein of interest, is the maltose binding 
protein (MBP) from E. coli. This protein has a molecular weight of 40 kDa and has the ability 
to bind to a cross-linked amylose matrix. The binding affinity is in the micro molar range 
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and the tag can be used in a pH range from 7.0 – 8.0, however, denaturating buffer 
conditions are not possible (di Guan, Li et al. 1988). The elution of the recombinant protein is 
recommended with 10 mM maltose. A great opportunity of the MBP-tag is the increasing 
solubility effect of the recombinant protein in prokaryotic expression systems and even 
more pronounced in eukaryotic systems (Sachdev and Chirgwin 1999). Like the CBP-tag, a 
fusion at the N-terminal side might influence translation and expression rates (Sachdev and 
Chirgwin 1999).  
3.1.6 Tag position and double tags 
As described above, the position of the tag either at the N- or C-terminus has a considerable 
influence on translation and expression rate as well as on the biological function (Arnau, 
Lauritzen et al. 2006). If information regarding activity of the protein is already available 
especially about the location of interaction sites, this should be included in the protein 
design, meaning tag position etc. In general, the tag should be placed at the position of the 
protein, which is less important for interactions and/or expression. To minimize the 
influence of the tag on folding and/or activity in some cases it helps to create a linker region 
of a few amino acids between the tag and the protein (Gingras, Aebersold et al. 2005). A 
very efficient and sophisticated solution is, the addition of amino acids between tag and 
protein of interest, which functions not only as an accessibility increasing factor, but, also 
encodes for a recognition site for proteases like thrombin or TEV. Due to this arrangement 
the tag – protein interaction is minimized and the tag can be cleaved off if necessary (Arnau, 
Lauritzen et al. 2006). In some special cases a combination of two affinity tags results in 
enhanced solubility and more efficient purification. To enhance the purity of a protein, often 
a construct of two different short affinity tags like his-tag and Strep-tag or CBP-tag can be 
engineered (Rubio, Shen et al. 2005). Also a combination of two his-tag or two strep-tag kept 
apart by a linker region enhances the binding affinity extremely. This allows more stringent 
washing steps prior to elution of the protein (Fischer, Leech et al. 2011). 
3.2 Size exclusion chromatography and ion exchange chromatography 
Despite the usage of affinity tags a second purification step is sometimes required (Figure  
1 – (II) purification). Which kind of purification procedure is required depends on the nature 
of impurities. If these impurities differ in molar mass compared to the protein of interest, a 
method based on size separation can be applied. Size exclusion chromatography (SEC) also 
separates different oligomeric species of the protein from each other, which otherwise 
would strongly inhibit crystallization and also allows analysis of stability and 
monodispersity of the protein (Regnier 1983a; Regnier 1983b).  
However, in many cases, SEC is not sufficient to remove all impurities. Then separation by 
overall charge of the protein might be an option. Depending on the isoelectric point of the 
protein either anion or cation exchange chromatography can be performed. The protein 
binds to a matrix under very low ionic strength and is eluted afterwards either by increasing 
the ionic strength or by pH variation. Similar results can be achieved by hydrophobic 
interaction chromatography. Here, proteins with different surface properties show 
differences in their binding strength and binding of the protein is done inversely as during 
ion exchange chromatography. High ionic strength favors protein binding to a hydrophobic 
matrix and elution takes place when reducing the ionic strength. Although there are many 
other possibilities to increase the purity of a protein, the above mentioned techniques are 
without any doubt the most widely used and general applicable methods. 
www.intechopen.com
 Modern Aspects of Bulk Crystal and Thin Film Preparation 
 
506 
3.3 How to get a homogenous protein solution 
In some cases isolated proteins are stable and homogenous at high concentrations after the 
purification and can be directly used for crystallization experiments. Often, however, the 
protein does not behave ideal and precipitates at high concentrations or forms aggregates or 
inhomogenous, oligomeric species; all of them prohibit crystal growth. SEC is a very elegant 
method to visualize the stability and oligomeric state of a protein. If the stability or the 
homogeneity of a protein sample is critical, you need to adapt your purification protocol 
and search for an optimized procedure. Different approaches are summarized below, for 
example a buffer screen to enhance protein solubility, multi-angle light scattering 
experiments to determine the absolute mass and the oligomeric state of the protein sample 
or fluorescence-based experiments to investigate the stability of the protein of interest.  
3.3.1 Purified proteins – An in vitro system 
After a protein is expressed in a soluble form, the subsequent purification procedure 
changes the environment of the protein dramatically. The cytoplasm of the cells, where the 
overexpression takes place, is packed with macromolecules. In E. coli, for example, the 
concentrations of proteins, RNAs and DNAs are about 320 mg/mL, 120 mg/mL, and 18 
mg/mL, respectively (Cayley, Lewis et al. 1991; Zimmerman and Trach 1991; Elowitz, 
Surette et al. 1999) resulting in an overall concentration of macromolecules of above 450 
mg/mL. During cell lysis and the first purification step, likely an IMAC (see above), the 
protein is separated from almost all other cell components. This rigorous procedure is 
accompanied with a severe change of the environment into an in vitro system. As a result 
proteins often tend to aggregate, precipitate or form inhomogeneous oligomeric states that 
prevent the formation of crystals in further experiments. Therefore one of the biggest 
challenges in structural studies is the preparation of protein solutions with high 
concentrations (as a rule of thumb 10-20 mg/mL) in a homogenous state. To fulfill these 
requirements, the in vitro system needs to be optimized with respect to different parameters 
as highlighted in Figure 1 – (II) purification. If a sufficient protein sample cannot be obtained, 
different strategies are available to increase the important characteristics of the protein: 
purity and homogeneity. As mentioned above, the usage of different metal ions during 
IMAC, ion exchange, a second affinity chromatography etc. can be sufficient to enhance 
purity. This might also lead to an increased stability. However, if the stability and/or 
homogeneity of a protein is still a problem, screening for a new buffer composition is 
essential to succeed during crystallization trials. 
3.3.2 Buffer composition  
Many examples illustrate the importance of an adequate buffer composition for protein 
stability, homogeneity, conformation, and activity (Urh, York et al. 1995; Holm and Hansen 
2001; Jancarik, Pufan et al. 2004; Collins, Stevens et al. 2005). Some buffers are very 
frequently used and recommended by manufactures (see for example Qiagen, Roche, New 
England BioLabs, Fermentas, etc.). All of them contain a buffer reagent that keeps the pH 
constant in a well-defined range. Well-known examples are phosphate, tris (hydroxymethyl) 
aminomethane (Tris), or HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) that 
buffer at the physiological relevant pH range of 6- 9 (Durst and Staples 1972; Chagnon and 
Corbeil 1973; Tornquist, Paallysaho et al. 1995). In recent years, the development of other 
buffer systems has been quite successful (Taha 2005) (for a list of buffers and corresponding 
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pH ranges, see for example: http://delloyd.50megs.com/moreinfo/buffers2.html). Next to 
the well-defined pH, the stability and homogeneity of proteins depend on many other 
parameters, for example ionic strength, the presence of ligands and/or co-factors,  divalent 
ions, glycerol, etc. The appropriate buffer composition cannot be predicted so far and needs 
to be identified by trial-and-error approaches.  
3.4 Protein purification – How to overcome problems 
In this part we would like to present some pitfalls that might occur during protein 
purification and provide some ‚rationales’ to overcome these problems. As usual, the crucial 
step of solving a problem is its identification. Here, we are trying to sensitize the reader to 
indications, which might point towards problems related to instability and/or 
inhomogeneity of the protein sample. Moreover, such problems cannot always be 
recognized without the adequate technique(s). Therefore, we are introducing techniques 
that are capable to visualize the state of proteins. 
3.4.1 Visible protein precipitations during IMAC 
A very obvious stability problem is the formation of precipitations in the elution fractions of 
a chromatography step (see Figure 2). In this example, the his-tagged protein was eluted 
with a linear imidazole gradient from 10 to 500 mM imidazole and eluted at about 250 mM 
imidazole. Protein precipitation occured immediately after elution (Figure 2A and B) and 
continued (Figure 2C) resulting in a low amount of soluble protein. This aggregation can be 
reduced by dilution with a IMAC buffer (typically lacking imidazole) immediatly after the 
elution. Thereby, dilution hinders the concentration-dependent aggregation. In many cases, 
this rational is not sufficient to prevent precipitation. After applying, for example, a  
buffer screen (see Figure 1 – (II) purification) the new defined buffer is used for the 
chromatography or the eluting protein is diluted into the new buffer (see Figure 2D). 
Other elution strategies of his-tagged proteins from an IMAC column are available. As 
described before, competing the poly-histidine from the IMAC column by imidazole is the 
most common elution strategy, however, for some proteins other strategies are superior, for 
example, replacing imidazole by histidine. Imidazole is only a mimic for histidine. If one 
uses histidine instead of imidazole aggregation can be avoided as concentration of the 
eluent can be reduced by a factor of ten. An example for a protein sensitive to imidazole 
concentration is shown in Figure 3B. Here a comparative SEC chromatogram is shown. After 
elution from the IMAC column with imidazole only a very small amount of the protein 
elutes at the volume corresponding to the size of a monomer or the dimer, respectively 
(Figure 3B, continuous line). Most of the protein passes the column very fast and elutes at 
the void volume indicating large radii meaning aggregated protein. Yields of dimeric (at 
about 150 mL) and monomeric (at about 180 mL) proteins are strongly increased after an 
elution with histidine (dashed line) compared to an elution with imidazole (continous line) 
and only the monomeric species could be crystallized (data not shown). The choice of the 
eluent in IMAC might therefore be an important step in a purification protocol. Another 
elution strategy of his-tagged proteins is a pH change from 8 to 4. In an acidic environment, 
histidines become positively charged and are therefore released from the column matrix. 
This strategy results in a sharp elution from the matrix and the protein is eluted highly 
concentrated. Although this strategy is recommended by the manufacturers (see GE 
Healthcare, Qiagen, etc.) the desired protein needs to retain activity at acidic pHs. The 
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bivalent metal ions (Ni2+, Co2+, Zn2+,…, see above) that complex the his-tag can be removed 
from the matrix by chelating reagents as ethylenediaminetetraacetic acid (EDTA) as another 
elution strategy (Muller, Arndt et al. 1998) 
 
 
Fig. 2. Elution fractions of an IMAC. The protein was eluted via a linear imidazole gradient 
from 10 to 500 mM and the absorption at 280 nm was recorded. The elution fractions were 
collected and photographed. A: IMAC chromatogram of the his-tagged protein. Elution 
fractions containing the desired protein (indicated by a bar) are collected and shown in  
B – D. B and C: Elution fractions of the protein in 50 mM Tris-HCl, 150 mM NaCl, pH 8.0 
immediately and 10 min after the elution, respectively. D: The elution fractions were 
immediately mixed in a 1 to 1 ratio with a buffer that enhances the protein stability  
(50 mM citrate, 50 mM LiCl, pH 6.00) evaluated during a solubility screen. 
3.4.2 Invisible aggregations 
Sometimes aggregation of proteins in solution can not be detected directly by eye. This 
inhomogeneity of protein samples can be visualized SEC, a method that separates proteins 
by their hydrodynamical radius (see above). Protein aggregates are eluting at the void 
volume, since they are clumbed together resulting in a big hydrodynamical radius (see 
Figure 3A and B). If invisible aggregation is detected the buffer composition needs to be 
adjusted. In one case we applied this technique to visualize the state of a protein after an 
IMAC, and the resulting elution profile is shown in Figure 3A (continous line). Comparable 
to the imidazole-induced precipitation described above, the protein aggregated and elutes 
within the void volume of the column (about 40 mL). Moreover, several other protein 
species elute from 55 to 80 mL indicating a highly inhomogeneous protein sample. The 
running buffer of the SEC was 50 mM Tris-HCl, pH 8.0 and 150 mM NaCl. Remarkably, a 
simple change to a new buffer (20 mM HEPES, 150 mM NaCl, pH 7.0) Resulted in a stable 
and homogenous protein sample (Figure 3A, dotted line), which was suitable for 
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crystallization trials. Next to the rigorous change in the homogeneity of the protein, the 
biological activity of the protein could only be determined in the new buffer system. The 
influence of the buffer composition for the protein activity is a well-known phenomenon 
(Urh, York et al. 1995; Holm and Hansen 2001; Zaitseva, Jenewein et al. 2005) and in many 
cases the activity goes hand in hand with an optimal buffer for the purification. 
Mentionable, the new buffer was not found by trial-and-error approaches. We searched for 
literature dealing with homologous proteins, especially for established purification 
protocols. This literature search revealed the new buffer, illustrating that not every step 
towards a protein structure determination must be a trial-and-error process.  
 
 
Fig. 3. Size exclusion chromatograms (UV 280nm) of proteins in different buffers. A: The 
homogeneity of a protein was analyzed in two different buffers; continuous line: 50 mM 
Tris-HCl, 150 mM NaCl, pH 8.00; dotted line: 20 mM Hepes, 150 mM NaCl, pH 7.00. B: The 
protein was eluted of the IMAC column either with imidazole (continous line) or with 
histidine (dotted line), concentrated and applied to the SEC. 
Another example for the influence of the buffer composition was published bei Mavaro et al. 
(Mavaro, Abts et al. 2011). Instead of the buffer agent, the ionic strength of the buffer was 
the crucial determinant. Purification of the protein in low-salt buffer resulted in an 
inhomogenous protein sample containing a mixture of aggregates, dimers and monomers 
without biological activity. However, a simple change to high-salt buffer allowed the 
purification of homogenous dimeric protein, that was able to bind its substrate. 
3.4.3 Overcoming protein instability 
In the previous sections different strategies were mentioned to enhance the stability and the 
homogeneity of purified proteins and in all cases the buffer composition was the solution. 
Still, the essential question how to determine the optimal buffer to make a protein feel 
happy in solution is not answered? Some rationales and experiences are listed above: 
different elution strategies for IMAC purifications, the usage of frequently used buffer 
agents and a literature research for established purification protocols of related proteins. 
However, in many cases these approaches do not solve the problems occuring during the 
purification. But, is there a general methodology to overcome the problems? Unfortunately, 
the answer is as frustrating as challenging - there is not a general panacea around for the 
right buffer composition of a protein. If a new buffer needs to be found, trial-and-error 
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approaches have to be applied. A lot of different parameters are influencing the state of a 
protein, i. e. the buffer agent, the salt concentration, presence of metal ions with different 
valences, the hydrophobicity, and even the temperature of the buffer. The analysis of the 
protein in different buffers can be done by SEC and/or light scattering experiments. 
However, screening of all the different variables is very labor- and cost-intensive, and time-
consuming, moreover only combinations of two or more additives might be sufficient to 
enhance the solubility and homogeneity of the protein. Therefore high-throughput methods 
are needed that handle a lot of different conditions simultaneously using as few as possible 
protein sample.  
3.4.4 Buffer screen – Enhancing the solubility 
Many publications are available suggesting methods for a solubility screening to allow the 
crystallization of initially inhomogeneous, aggregating protein samples (Jancarik, Pufan et 
al. 2004; Zaitseva, Holland et al. 2004; Collins, Stevens et al. 2005; Sala and de Marco 2010; 
Schwarz, Tschapek et al. 2011). In all of these methods aggregating protein samples are 
mixed with commercially available crystallization screens incubated for a period of time, 
and analyzed for precipitation visually using a light microscope. Screening conditions 
resulting in no precipitations are analyzed upon their composition, and protein samples 
are further examined with respect to their solubility and homogeneity under these 
conditions by SEC or light scattering experiments. This technique allows high-throughput 
screening in a 96-well format, where an automated pipetting system mixes only 50-200 nL 
of protein solution with 50-200 nL of buffer solutions to minimize the needed protein 
sample and increase the screening efficiency. Several buffer screens are commercially 
available that cover many different buffer agents, salt concentrations and other buffer 
parameters (i. e. from Hampton Research, Molecular Dimensions, Sigma, Jena Bioscience, 
Qiagen). After a solubility screening was applied, we were able to stabilize a previously 
unstable protein at concentrations above 3 mg/mL (see above "Protein precipitations 
during IMAC" and Figure 2D) at concentrations of up to 100 mg/mL for weeks (Schwarz, 
Tschapek et al. 2011). Typically, the new buffer (50 mM citrate, 50 mM LiCl2, pH 6,00) 
should be used during the entire purification procedure starting with cell lysis. In the 
described case, the new buffer contains citrate, which is incompatible with an IMAC 
purification. Therefore the protein was immediately mixed with the new buffer after the 
elution of the IMAC column.  
3.4.5 Size-exclusion chromatography versus light scattering experiments 
Size-exclusion chromatography (SEC) and light scattering experiments (LS) are very helpful 
tools to analyze the homogeneity (Collins, Stevens et al. 2005) and the molecular mass of 
proteins; however both of them have advantages and disadvantages compared to each 
other. In SEC experiments proteins are separated based on their hydrodynamic radius by 
partitioning between a mobile phase and a stationary liquid within the pores of a matrix. All 
SEC columns are characterized by the volumes V0, the liquid volume in the interstitial space 
between particles, Vi, the volume contained in the matrix pores and VT, the total diffusion 
volume (V0 + Vi) (Regnier 1983a; Regnier 1983b). In dependency of the hydrodynamic 
radius molecules are eluting at specific retention volumes in between V0 and VT with big 
molecules eluting first. After a calibration of a SEC column with proteins of known 
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molecular weight (i. e. Sigma-Aldrich, "Kit for Molecular Weights") the molecular mass of 
the protein of interest can be roughly estimated; the elution volume is correlated to the log10 
of the molecular weight (therefore, the hydrodynamic radius is considered to be 
proportional to the molecular weight). However, many extraneous mechanisms such as 
adsorptive, hydrophobic and ionic effects are further limiting the correlation between the 
retention volume and the molecular mass giving sometimes rise to wrong estimations.  
Light scattering (LS) experiments can be applied to overcome these disadvantages and 
investigate the exact molecular weight of the protein sample. The rayleigh scattering of 
particles of monochromatic light depends directly on the molar mass of the particle. If you 
know the exact number of particles you can calculate the average molar mass of these 
particles. This technique is very powerful when used online after separation of the protein 
depending on their hydrodynamic radius, meaning SEC. This technique is always superior 
to normal SEC but requires special equipment and especially more time. However, if the 
protein fold is not really globular or other effects occur (see above: ionic, hydrophobic, etc.) 
assumption on size and oligomeric state based on SEC is not possible at all. For protein 
crystallization information about monodispersity, which can be provided by such an 
experiment, is an additional benefit.  
3.4.6 Analysis of the homogeneity – High-throughput methods 
Despite the development of various sophisticated methods, a bottleneck of homogeneity 
screening is high-throughput analysis. As mentioned above, proteins need to be analyzed by 
SEC and/or LS experiments after visual read-out of the protein-buffer droplets. Therefore, 
fluorescence-based solubility screens were developed that allow the high-throughput 
analyzes of many samples in a 96-well format (Ericsson, Hallberg et al. 2006; Alexandrov, 
Mileni et al. 2008; Kean, Cleverley et al. 2008). All these assays use fluorophores as reporters 
of the protein state. A suitable fluorophore is, for example, Sypro Orange, which exhibits 
different fluorescence properties as a function of its environment. This dye is almost dark in 
hydrophilic environment, however, after binding to hydrophobic molecules, it emits light at 
570 nm. In inhomogenous and unfolded protein samples hydrophobic amino acids are 
exposed to the surface of proteins (Murphy, Privalov et al. 1990). An increase in the 
fluorescence signal of Sypro Orange correlates therefore with unfolding events of proteins. 
The homogeneity screening can be performed in basically two ways: temperature- or time-
dependent. For the first setup the protein sample is heated gradually in distinct steps (i. e. 1 
°C) and the emission is monitored at 570 nm. Hereby, a "melting" temperature is 
determined, which is characterized by 50% fluorescence of the maximal fluorescence at the 
highest temperature; the higher the melting temperature, the higher the stability of the 
protein (Ericsson, Hallberg et al. 2006). Secondly, the protein sample is incubated at a 
specific temperature (i. e. 40°C) and the fluorescence is measured for a period of time. The 
"half-life" time, at which 50 % fluorescence of the maximum fluorescence in one sample is 
detected, can be compared to all buffer conditions. In Figure 4 an example of the time-
dependent approach is shown. Here, the protein is incubated in different buffers with 
various salt concentrations. The emission of Sypro Orange is recorded each minute at 570 
nm. An analysis of all time-dependent fluorescence plots indicates that the protein is most 
stable in buffers containing 125 mM NaCl but unfolds fast in 1 M ammonium sulfate. These 
assays result in qualitative indications about a favourable environment of proteins that 
enhance the stability. Ericsson et al. proved the concept of this method by applying it to 
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different proteins (Ericsson, Hallberg et al. 2006). The stability optimization yielded a 
twofold increase in initial crystallization leads. Moreover these assays enable the search for 
putative ligands of the protein. Upon binding of a substrate in the binding pocket or an 
inhibitor, the stability of the protein increases, which can be detected experimentally. 
 
 
Fig. 4. Time-dependent stability optimization screen using Sypro Orange as reporter. The 
protein is diluted 1:50 into each test buffer containing Sypro Orange, excited with 490 nm 
and the fluorescence at 570 nm is measured for 60 minutes automatically with a PLATE 
READER (Fluorostar, BMG Labtech). Normalized fluorescence is plotted against the time. 
4. Protein crystallization: Introduction 
Protein crystals suitable for X-ray diffraction experiments and usable for subsequent 
structure determination are normally relatively large with a size of at least 10 to 100 m. In 
contrast to crystals of mineral compounds, protein crystals are rather soft and sensitive to 
mechanical stress and temperature fluctuations. These properties are due to weak 
interactions between single proteins within the crystal, their high flexibility as well as the 
size of the macromolecules. The periodic network of building blocks is held together by 
dipole-dipole interactions, hydrogen bonds, salt bridges, van der Waals contacts or 
hydrophobic interactions. All of them have binding energies in the low kcal/mol range.  
Especially the limited number of crystal contacts and their directionality are the largest 
difference to the high interactions generally observed in salt crystals. An example of the 
interactions within a protein crystal is shown in Figure 5. This picture highlights the main 
pitfalls in protein crystallization. A protein is a highly irregular shaped and flexible 
macromolecule which allows weak and stinted interactions at very specific locations of its 
surface. All vacuity is filled with buffer, in general not contributing to any kind of 
interactions between the protein molecules. Figure 5A shows a protein of around 30 kDa, 
which crystallizes in a rather small unit cell (shown in black). Only one protein monomer is 
located in the asymmetric unit of the unit cell, the other shown monomers represent 
symmetry related proteins. Figure 5B highlights the three-dimensional packing of protein 
molecules within a crystal.  
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Fig. 5. Example of the packing within a crystal. A: The unit cell is shown in black, crystal 
contacts are highlighted with purple circles and lines. B: Three-dimensional crystal packing 
of a different protein. The unit cell as well as one protein monomer are depicted in green. 
The flexibility as well as the other mentioned characteristics of proteins are responsible for 
the problems occuring during crystallization trials and despite extensive efforts not every 
protein is suitable for crystallization. If one cannot generate crystals one has to move back 
several steps and change the properties of the protein, e. g. surface properties by mutation of 
single amino acids, truncation of the protein or sometimes only changing buffer 
compositions that result in a more suitable protein for crystallization (see Figure 1 and also 
below). There are several prediction servers available that help choosing the ‘right’ protein 
and modification (Linding, Jensen et al. 2003; Goldschmidt, Cooper et al. 2007). However, 
protein crystallization still remains an empirical approach, sometimes called voodoo, while 
crystallography is science. 
4.1 Phase diagram 
The conditions or protocols for obtaining good crystals are still poorly understood and 
despite all progress and efforts protein crystallization is a trail-and-error approach. 
However, a step towards a better understanding of crystal growth can be achieved by 
analyzing the phase diagram of a protein-water mixture. The phase diagram is a simple 
illustration to help understanding how protein crystals are formed. Mostly, it is shown as a 
function of two ambient conditions that can be manipulated, i. e. the temperature and the 
concentration. Three-dimensional diagrams (two dependent parameters) have also been 
reported (Sauter, Lorber et al. 1999) and even a few more complex ones have been 
determined as well (Ewing, Forsythe et al. 1994). Figure 6 shows a schematic phase diagram 
for a protein solution as a function of protein concentration and precipitant concentration. 
The phase diagram is broken down into four distinct zones (Rosenbaum and Zukoski 1996; 
Haas and Drenth 1999; Asherie 2004): 
1. Undersaturated zone: Under these condition the protein will stay in solution as neither 
the concentration of the protein nor of the precipitant is high enough to reach 
supersaturation. 
2. Precipitation zone: Is the protein concentration or the precipitant concentration too 
high, the protein precipitates out of solution; this kind of solid material is not useful for 
crystallographic studies. 
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3. Labil zone: This is the most important configuration of the two parameters, as 
nucleation and initial crystal growth take place under these conditions. 
4. Metastable zone: After initial crystals are formed and start growing in the labil zone, 
protein concentration decreases in the drop and the metastable zone will be reached. 
Here the crystal can grow further to its final maximum size. 
 
 
Fig. 6. A basic solubility phase diagram for a given temperature (adapted from (Rupp 2007). 
The curve separating the undersaturated zone from the supersaturated one is called 
solubility curve. If conditions are chosen below the solubility curve, the protein will stay in 
solution and never crystallize. This means when a protein crystal is placed in a solvent, 
which is free of protein, it will start to dissolve. If the volume of the droplet is small enough 
it will not dissolve completely: it will stop dissolving when the concentration of the protein 
in the droplet reaches a certain level. At this concentration the crystal loses protein 
molecules at the same rate at which protein associate to the crystal – the system is at 
equilibrium. Determination of the solubility of the protein of interest might be a helpful 
information at the beginning of crystallization experiments. This can be done in a two-
dimensional screen varying for example ammonium sulfate concentrations as well as the 
protein concentration.  
4.2 Crystallization techniques 
Crystallization is a phase transition phenomenon. Protein crystals grow from a 
supersaturated aqueous protein solution. Varying the concentration of precipitant, protein 
and additives, pH, temperature and other parameters induce the supersaturation. However, 
as mentioned before, prediction of this kind of phase diagrams is a priori impossible. 
Protein crystallization can be divided into two main steps:  
1. Generating initial crystals: ‘Searching the needle in a haystack’ 
2. Empirical optimization of these crystallization condition 
The first step is mostly based on experiences from other crystallization trials with different 
proteins. Nowadays several supplier offer crystallization screens that contain solutions for 
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initial experiments that were used successfully in the past for crystallization trials (Jancarik 
and Kim 1991), so-called “sparse matrix screens”. There are also some trials around to use 
more systematic approaches (Brzozowski and Walton 2000) to get more information about 
solubility prior and simultaneous to crystallization (incomplete factorials, solubility assays). 
Both kinds of screens can be applied to different crystallization techniques. 
 
 
Fig. 7. Crystal optimization. First steps in crystal optimization are shown. Initial protein 
crystals look weak and fragile, after screening around this initial buffer composition 
crystal evaluation by eye results in less fragile, homogeneous looking crystals. However, 
diffraction quality was poor. Therefore an additive screening was performed that resulted 
in a different crystal form. These crystals finally were able to diffract X-rays to a 
reasonable resolution. 
A lead/hit in that initial step might not be a ‘real’ crystal rather than a crystalline precipitate 
or just phase separation. In the next step, fine-tuning the buffer composition further 
optimizes this hit. Varying pH, salt concentration, type and concentration of precipitant and 
protein concentration are expected to yield larger and hopefully also better-diffracting 
crystals. In this step, the chemicals used are much more defined and therefore it is a more 
systematic than empirical screening (see Figure 7). 
4.2.1 Vapor diffusion 
The most popular and simplest technique to obtain protein crystals is the vapor diffusion 
method either in the sitting or hanging drop variant (see Figure 8). For both a defined 
volume (mostly < 1µl) of protein solution is mixed with an equivalent volume of screening 
solution and then equilibrated against the original precipitant/screening concentration. 
During this equilibration, the vapor pressure of the solution rises as the protein crystallizes 
(protein in solution lowers water activity) while the water evaporates to maintain 
equilibrium, which causes the precipitant concentration to rise. Therefore, if the crystal 
growth is sensitive to the precipitant concentration, vapor diffusion can rapidly force the 
mixture to unstable conditions where growth and nucleation are too rapid. This is the main 
disadvantage of vapor diffusion: Growing large crystals might be problematic!  
4.2.2 Micro batch method 
In this set-up the protein solution is mixed with screening solution at concentrations 
required for supersaturation right at the beginning of the experiment. Typical drop sizes 
of micro batch experiments ranges from 1-2 µl. The drop is then covered with oil, which 
acts as an inert sealing to protect the drops during incubation from evaporation (see 
Figure 8). 
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Fig. 8. Protein crystallization techniques. Schematic representation of a) vapor diffusion, b) 
micro batch and c) micro dialysis crystallization techniques widely used for crystal growth 
(adapted from (Drenth 2006)). 
4.2.3 Micro dialysis 
Dialysis is another way to change the buffer composition and increase its concentration in 
the crystallization experiment gradually (see Figure 8). Micro-dialysis buttons are exposed 
to different screening buffers. This method requires rather high amounts of protein but 
might yield large crystals.  
After obtaining initial crystal hits in a commercial screen the tough part of crystal 
optimization starts. By varying pH, salt concentration, temperature, precipitant 
concentration or protein concentration these initial crystals should be reproduced and 
become larger, more regular shaped or are simply growing faster. A further improvement of 
crystal quality might be achieved by the addition of small amounts of so called ‘additives’. 
At this point basically each chemical compound might be sufficient to improve the crystal 
quality. Luckily, there are some preferable working additives, which have been proven to 
produce better crystal in more than one case. Especially compounds that are known to 
reduce undirected interactions in proteins like organic solvents, i. e. DMSO or phenol, or 
detergents and reducing agents are very often used at this stage and helpful to force more 
homogeneous well diffracting crystals. 
4.3 Crystal nucleation 
There are two fundamental steps during protein crystallization: Nucleation and crystal 
growth. If one cannot obtain single crystals of adequate quality for analysis, this is generally a 
consequence of problems associated with the growth phase (see above). But failure to obtain 
any crystals at all or failure to obtain single, supportable nuclei reflects difficulties in the 
nucleation step. Therefore control of nucleation is a powerful tool to optimize protein crystals 
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or sometimes it is the only way to get crystals at all. Nucleation can take place either 
homogeneous meaning in the bulk of the solution, when the supersaturation is high enough 
for the free-energy barrier to nucleus formation to be overcome or heterogeneous mostly by 
solid material in the crystallization solution. This can also occur even when the 
supersaturation is not achieved. Therefore in order to control nucleation one has to work with 
highly clean solutions to avoid nucleation by the second mentioned possibility. The nucleation 
zone can be bypassed by insertion of crystals, crystal seeds or other nucleants to the 
protein/precipitant mixture. Addition of crystals or tiny fragments of crystals is called 
seeding. This method is then subdivided into macro- and micro-seeding dependent on the size 
of the nucleant added. In macro-seeding experiments one single, already well-formed but 
small crystal is placed into a new crystallization solution at lower saturation. Microseeding in 
contrast requires small fragments of a crystal or almost invisible microcrystalline precipitate. 
These ‘seeds’ are then transferred into a fresh crystallization solution either by a seeding wand 
which is dipped into the microseed mixture to pick up seeds and then touched across the 
surface of the new drop or by a animal whisker or hair that is stroked over the surface of the 
parent crystal to trap the nuclei and then is drawn through the new drop. As this method also 
enhances the speed of crystal growth it can be used with sensitive substrate that undergo 
decomposition over time. Oswald et al. proved this in 2008 by solving the structure of ChoX 
from Sinorhizobium meliloti in complex with a highly hydrolyzing substrate, acetylcholine 
(Oswald, Smits et al. 2008). In classical vapor diffusion experiments crystals appear after four 
weeks but data showed only little electron density in the ligand-binding site and turned out to 
result from a choline bound instead of acetylcholine. Hydroxylation was favored due to the 
relatively long time for crystal growth but also because of an acetic pH in the crystallization 
set-up. To circumvent these problems accelerated crystal growth was required. In this case 
micro-seeding results in crystals suitable for data collection in less than 24 hours.  
Recent years more effort in nucleation control yielded in fancy materials that can be used as 
nuclei for crystals. These methods use the second way of nuclei formation, as a solid 
material is introduce into the crystallization solution as an ‘universal’ nucleant (Chayen, 
Saridakis et al. 2006). There have been several substances that have been tried more or less 
successful. Some have been useful for individual proteins, but mostly they were not 
applicable in general (McPherson and Shlichta 1988; Chayen, Radcliffe et al. 1993; Blow, 
Chayen et al. 1994). In 2001, Chayen et al. proposed the idea of using porous silicon whose 
pore size is comparable with the size of a protein molecule. In theory such pores may 
confine and concentrate the protein molecules at the surface of the silicone and thereby 
encourage them to form crystal nuclei (Chayen, Saridakis et al. 2001). These nucleants have 
made it to commercial availability (www.moleculardimensions.com) and have proven to be 
suitable for different kinds of proteins and even membrane proteins that have not been 
possible to crystallize before formed nice crystals in the presence of these nucleants. 
4.4 Cryoprotection 
Exposure of a protein crystal at room temperature results in dramatic radiation damage due 
to radicals formed by the ionizing X-ray photons. To reduce that harmful disintegration of 
the protein crystal the crystal is cooled to 100K with the help of liquid nitrogen (Low, Chen 
et al. 1966; Hope 1988; Rodgers 1994; Garman 1999). However, it is common for the cooling 
process to disrupt the crystal order and decrease diffraction quality. Thus, the crystal must 
be cooled fast so that the water in the solvent channels is in the vitreous rather than in the 
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crystalline state at the end of this procedure. As for pure water this cooling has to take place 
very quick (10-5s, (Johari, Hallbrucker et al. 1987), some water molecules can be replaced by 
a cryoprotective solution prior to cooling (Juers and Matthews 2004). This exceeds the time 
window for freezing up to 1-2s (Garman and Owen 2006) however, finding a good 
‘cryoprotectant’ for a special protein crystal again involves substantial screening. Once flash 
frozen in liquid nitrogen, the crystal must be kept below the glass transition temperature of 
the cryobuffer at or below 155K at all times (Weik, Kryger et al. 2001).  
4.5 What can you do when all efforts did not succeed in crystals? 
4.5.1 Buffer composition – Again! 
The choice of the right buffer used for crystallization experiments is very crucial. As shown 
above, every protein needs its own buffer composition to feel kind of happy in this aqueous 
artificial environment. Especially as high protein concentrations (>10mg/ml) are required 
for crystallization, one might has to test several buffer compositions again (see also Figure 
1). As a rule of thumb you should obtain around 50% of clear drops immediately after 
mixing protein and buffer solution. If you detect drastically more precipitation in your 
drops you should think first about lower protein concentration but of course secondly about 
changing your buffer system again. 
4.5.2 How to obtain a rigid protein suitable for crystallization? 
To overcome the problem of flexibility of some regions in the protein addition of ligands is 
often a very powerful tool to fix the protein in a single conformation that is more favorable 
for crystallization. A good example for this strategy is the crystallization of so-called 
substrate binding proteins (for a recent review see (Berntsson, Smits et al. 2010)). These 
proteins catch their substrate in the periplasm of bacteria or on the outer membrane of 
archaea and then deliver it to their cognate transport system located in the membrane. The 
mechanism of substrate binding is quite well understood. These binding proteins all consist 
of two domains, which rotate towards each other during the binding event. In solution 
without substrate they are quite flexible and NMR-studies proved a equilibrium between 
open and closed conformation (Tang, Schwieters et al. 2007). Analysis of all available 
structures for this class of proteins showed that more than 95% were crystallized with a 
ligand bound (Berntsson, Smits et al. 2010). Thus, a stabilization of the two domains seems 
to simplify crystal contact formation dramatically. Although people always want to obtain a 
functional conformation of the protein in their crystal structure, it is sometimes helpful to 
think about how to stop the protein from doing its job. A non-functional protein is in 
general less flexible and fixed in one conformation. One example for successful 
implementation of this strategy is the crystal structure of NhaA from Escherichia coli solved 
in 2005 (Hunte, Screpanti et al. 2005). Here, Hunte et al., downregulated the protein activity 
by working at an acidic pH of 4. Although the protein shows almost no activity at this pH 
the structure reveals the basis for mechanism of Na+/H+ exchange and also its regulation 
by pH could be understood. 
4.5.3 Rational protein design for crystallization: Surface engineering 
The first example of rational protein design that yielded a good diffracting protein crystal is 
given by Lawson et al. in 1991 (Lawson, Artymiuk et al. 1991). They compared amino acids 
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involved in crystal contact formation of the rat ferritin protein L. (which is highly 
homologous to human ferritin H, the target protein) with the amino acids present at that 
position in human ferritin H. A replacement of Lys86, found in the human sequence, with 
Glu, which occurs in rat, recreated a Ca2+ binding bridge that mediates crystal contacts in 
the rat ortholog. As this method was successful for several other proteins (McElroy, Sissom 
et al. 1992; Braig, Otwinowski et al. 1994; Horwich 2000), a general protocol was required. 
The concept Derewenda et al. proposed in 2004 is based on the general equation for the free 
energy that drives protein crystallization: 
( )protein solventG H T S S       
As the enthalpy values of intermolecular interactions in a crystal lattice are rather small 
(see above), crystallization is very sensitive to entropy changes of both protein and 
solvent. The formation of ordered protein aggregates carries a negative entropy term. This 
can only be overcome by positive entropy from the release of water bound to the protein. 
However, large hydrophilic residues (e.g. lysines, arginies, glutamates, glutamines) 
exposed on the protein surface need to be ordered. Since they are rather flexible this can 
cause problems. This can be overcome by mutating large amino acids into smaller ones, 
for example alanines. Among these large amino acids lysines and glutamates play a 
particular role, as they are always (with only very few exeptions) located on the protein 
surface (Baud and Karlin 1999). Both lysines and glutamates are typically disfavored at 
interfaces in protein protein complexes (Lo Conte, Chothia et al. 1999), therefore it is 
rather straight forward to assume that lysine and glutamate to alanine mutants are good 
targets for protein crystallization if wildtype protein hardly forms crystals. However this 
also means that you have to go several steps backwards on road to a protein structure 
determination (see Figure 1). 
4.5.4 Affinity tag removal: Philosophic question??? 
Another variant in protein crystallization nowadays is the affinity tag used for purification 
of the desired protein. The decision about position and choice of the affinity tag are mostly 
made at the beginning of the long way to a crystal structure (see Figure 1). However, it 
becomes crucial again at the crystallization step. In general most people like to remove the 
tag before crystallization to prove a physiological conformation. But, there are examples 
where the tag played a pivotal role in crystallization (Smits, Mueller et al. 2008a). The crystal 
structure of the octopine dehydrogenase from Pecten maximus is shown in Figure 9 (Smits, 
Mueller et al. 2008b), with the interactions sides/crystal contacts highlighted in green. 
In Figure 9A contacts look quite similar to that presented in Figure 5. However when having 
a closer look on the his-tag, you recognize that it is located in a cavity formed by another 
monomer of that protein. In that cavity it can perform several hydrogen bonds with amino 
acids from the other monomer resulting in a very strong interaction which yields good 
quality crystals. 
4.5.5 Crystallization using antibody fragments 
A number of ways to stabilize proteins for crystallography have been developed, for 
example genetic engineering, co-crystallization with natural ligands and reducing surface 
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entropy (see above). Recently, crystallization mediated by antibody fragments has moved 
into the focus of crystallographers especially to obtain crystals of membrane proteins 
(Ostermeier, Iwata et al. 1995; Hunte and Michel 2002). Membrane protein crystallization is 
even tougher compared to soluble proteins, because of the amphipathic surface of the 
molecules. As they are located in the lipid bilayer most of their surface is hydrophobic and 
must be covered to keep them in solution. This is maintained by detergents. The detergent 
micelles cover the hydrophobic surface and therefore this area is no longer available to form 
crystal contacts. Crystal contacts can only be formed by the polar surfaces of these proteins. 
As many membrane proteins contain only relatively small hydrophilic domains, a strategy 
to increase the probability of getting well-ordered crystals is required. Antibody fragments 
can play this role. They can be designed for binding at specific regions in the protein and 
then function as additional polar domain in the membrane protein complex (for example see 
(Ostermeier, Iwata et al. 1995; Huber, Steiner et al. 2007). 
 
 
Fig. 9. Crystal contacts in OcDH protein. A: Overall view on two monomers. Surface Crystal 
contacts are highlighted in the green circles. B: Zoom in on the His-tag of one monomer. The 
his-tag of one monomer in the crystal structure is located near the binding site in a deep 
cavity formed by the other monomer. Therefore it is able to form several hydrogen bonds 
(highlighted in green) with side and main chains of the other protein but also with the 
ligand bound in this binding site (orange). 
5. Conclusion 
For what reason do we effort so much work on good quality crystals? 
Single good quality crystals constitute an essential prerequisite for structural investigations 
of biological macromolecules using X-ray diffraction. The harder one works on crystal 
quality the easier the determination of a reasonable atomic model of the molecule of interest 
becomes. The vast majority of problems encountered in crystal structure determination can 
typically be traced back to data-quality issues caused by crystal imperfections. 
Consequently, although primary focus of structural biology is on the macromolecule that 
makes up a crystal, there is also considerable interest in the physical properties, nucleation 
www.intechopen.com
 Rational and Irrational Approaches to Convince a Protein to Crystallize 
 
521 
and growth of the crystals themselves. Statistics of various Structural Genomics Centers 
proved that protein crystallization is still despite all the progress in the technology of 
crystallization robotics is still a rather tough field in biological science. Success rate ranges 
for small prokaryotic proteins from 10-30% and decreases dramatically to a few percent for 
human proteins. The struggle obtaining crystals for protein structure determination is 
justified. After all efforst looking at electron density and subsequent the protein structure is 
still one of the most intriguing as well auspicious parts in structural biology 
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